A total of 1,091 patients diagnosed with early-stage breast cancer between January 2013 and December 2014 were identified, among which 52 HER2 IHC2+ patients with unknown FISH results and 262 HER2-positive patients were excluded. The gene discussed is ERBB2; the disease is breast carcinoma.